[1] MENDIS S, DAVIS S, NORRVING B.Organizational update:the world health organization global status report on noncommunicable diseases 2014;one more landmark step in the combat against stroke and vascular disease[J].Stroke, 2015, 46(5):e121. doi: 10.1161/STROKEAHA.115.008097
[2] HUANG SW, CHI WC, CHANG KH, et al.World health organization disability assessment schedule 2.0 as an objective assessment tool for predicting return to work after a stroke[J].DisabilRehabil, 2018, 40(21):2592. doi: 10.1007/s00520-018-4322-y
[3] HU HY, CHI WC, CHANG KH, et al.The World Health Organization Disability Assessment Schedule 2.0 can predict the institutionalization of patients with stroke[J].Eur J Phys Rehabil Med, 2017, 53(6):856.
[4] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J/CD].中国医学前言杂志(电子版), 2010, 2(4): 50.
[5] 李司司.脑动脉粥样硬化性狭窄合并颅内动脉瘤的危险因素及抗血小板聚集治疗对其出血风险的影响[D].上海: 中国人民解放军海军军医大学, 2018: 22.
[6] 窦曼曼, 陈盈, 马迪, 等.动脉粥样硬化易损斑块相关通路研究进展[J].中风与神经疾病杂志, 2019, 36(1):95.
[7] 刘依侬, 徐立.TRAF3 IP2/IKK/NF-κB信号通路在动脉粥样硬化中的研究进展[J].中国实验诊断学, 2019, 23(9):1659.
[8] DE ROSA S, ARCIDIACONO B, CHIEFARI E, et al.Type 2 Diabetes Mellitus and Cardiovascular Disease:Genetic and Epigenetic Links[J].Front Endocrinol (Lausanne), 2018, 9(2):23.
[9] 顾静彧, 吴晓, 张婷, 等.老年人动脉硬化检测的应用及与血清转化生长因子β1和结缔组织生长因子的相关性研究[J].中国全科医学, 2019, 22(38):1.
[10] 刘琰凤, 吐尔逊·沙比尔.缺血性脑卒中患者血清胱抑素C与颈动脉粥样硬化间关系的研究进展[J].中国动脉硬化杂志, 2016, 24(9):969.
[11] 徐文青.血清胱抑素C水平对冠心病患者诊断的临床价值[J].中国药物与临床, 2019, 19(24):4344.
[12] 杨化冰, 邹小娟, 高清华, 等.代谢性炎症与动脉粥样硬化内生热毒病机探讨[J].湖北中医药大学学报, 2019, 21(1):48.
[13] 邹兰, 李国良, 严小新.血浆中suPAR和D-二聚体水平与动脉粥样硬化性脑梗死患者斑块易损性相关研究[J].中国医药导报, 2019, 16(14):47.
[14] 唐勇.纤维蛋白原降解产物和D聚体预测急性冠脉综合征患者第二次事件的发生率[J].血栓与止血学, 2019, 25(3):370.
[15] RIDKER PM, EVERETT BM, THUREN T, et al.Antiinflammatory therapy with canakinumab for atherosclerotic disease[J].N Engl J Med, 2017, 377(12):1119. doi: 10.1056/NEJMoa1707914
[16] ALESSENKO AV, ZATEYSHCHIKOV DA, LEBEDEV AТ, et al.Participation of sphingolipids in the pathogenesis of atherosclerosis[J].Kardiologiia, 2019, 59(8):77. doi: 10.18087/cardio.2019.8.10270